Drug Type Biological products |
Synonyms TI520 |
Target- |
Mechanism- |
Active Indication- |
Inactive Indication |
Originator Organization TeraImmune, Inc.Startup |
Active Organization- |
Inactive Organization TeraImmune, Inc.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Discovery | US | TeraImmune, Inc.Startup | 17 Oct 2022 |